Once an arbitrator issues a decision, absolutely no appeal may be taken. a. True b. False ...

Author Question: Once an arbitrator issues a decision, absolutely no appeal may be taken. a. True b. False ... (Read 69 times)

Chloeellawright

Hero Member
Posts: 588

on: Jun 24, 2018

Once an arbitrator issues a decision, absolutely no appeal may be taken.
a. True
b. False
Indicate whether the statement is true or false

Question 2

By law, arbitrators may not award punitive damages; they must only calculate compensatory damages in disputes they resolve.
a. True
b. False
Indicate whether the statement is true or false

joechoochoy

Sr. Member
Posts: 306

Reply #1 on: Jun 24, 2018

Answer to Question 1

FALSE

Answer to Question 2

FALSE

Need homework help now?

Ask unlimited questions for free

Ask a Question

« previous next »

Did you know?

Elderly adults are living longer, and causes of death are shifting. At the same time, autopsy rates are at or near their lowest in history.

Did you know?

Stevens-Johnson syndrome and Toxic Epidermal Necrolysis syndrome are life-threatening reactions that can result in death. Complications include permanent blindness, dry-eye syndrome, lung damage, photophobia, asthma, chronic obstructive pulmonary disease, permanent loss of nail beds, scarring of mucous membranes, arthritis, and chronic fatigue syndrome. Many patients' pores scar shut, causing them to retain heat.

Did you know?

Blood is approximately twice as thick as water because of the cells and other components found in it.

Did you know?

Before a vaccine is licensed in the USA, the Food and Drug Administration (FDA) reviews it for safety and effectiveness. The CDC then reviews all studies again, as well as the American Academy of Pediatrics and the American Academy of Family Physicians. Every lot of vaccine is tested before administration to the public, and the FDA regularly inspects vaccine manufacturers' facilities.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.